NCT03232775

Brief Summary

Children with autism spectrum disorders (ASDs) have unique social-communication and behavior impairments that complicate their medical management. This study aimed to evaluate the effectiveness of using a picture schedule paired with a reinforcement system during the medical exam. Two groups (treatment and control) of children (ages 5 - 10 yrs) diagnosed with ASD and below average adaptive communication impairment were asked to participate. Following participation in an overview of autism diagnostic symptoms training, two teams (comprised of one chief medical resident and one nurse), blind to the study aim, conducted the study exams.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2007

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2007

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2011

Completed
6 years until next milestone

First Submitted

Initial submission to the registry

July 13, 2017

Completed
15 days until next milestone

First Posted

Study publicly available on registry

July 28, 2017

Completed
Last Updated

July 28, 2017

Status Verified

July 1, 2017

Enrollment Period

3.9 years

First QC Date

July 13, 2017

Last Update Submit

July 25, 2017

Conditions

Keywords

visual pedagogy

Outcome Measures

Primary Outcomes (1)

  • Change from baseline on the Aberrant Behavior Checklist-Community measure ( irritability and stereotypy subscales)

    Caregiver report form of subjects' behaviors.

    The end of the 15-minute waiting period and within 15 minutes after the completion of physical exam

Secondary Outcomes (2)

  • Number of study exam items completed during study exams

    Within 15 minutes after conclusion of each participant's study exam.

  • Change from baseline in Cooperation likert-scale rating form

    At study entry and within 15 minutes after the completion of study physical exams

Study Arms (2)

Treatment

OTHER

Treatment: Physical Exam with Visual Pedagogy and Structure

Other: Treatment: Physical Exam with Visual Pedagogy and Structure

Control

OTHER

Control: Physical Exam without Visual Pedagogy and Structure

Other: Control: Physical Exam without Visual Pedagogy and Structure

Interventions

Routine physical examination participants receive visual pedagogy and reinforcement (preferred food treat).

Treatment

Participants engage in routine physical examination without visual pedagogy and reinforcement (preferred food treat).

Control

Eligibility Criteria

Age4 Years - 10 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Chronological ages 4 to 10 years.
  • Presumptive diagnosis of Autistic Disorder or Asperger's Disorder prior to study admission from a psychologist or psychiatrist experienced with children who have autism.
  • Meets research criteria for Autistic Spectrum Disorder:
  • Meets cut-off scores for autism spectrum on the Social Communication Questionnaire (SCQ) (cut-off = 15) and
  • Meets empirically-derived algorithm cut-off scores for Autism Spectrum Disorders on the Autism Diagnostic Observation Schedule (ADOS).
  • All subjects will have the ADOS administered by a clinician trained in research reliability standards.
  • The Principal Investigator, a certified ADOS trainer and research reliable, or trained designee under the supervision of the Principal Investigator, will administer the ADOS.
  • Participants will represent the typical DSM-IV diagnostic developmental profile of children on the autism spectrum and no neurological injuries or illnesses before the age of three years that could account for their symptoms (i.e., meningitis, encephalitis, severe head injury or seizure disorder).
  • A Communication standard score ≤ 85, as measured by the Vineland Adaptive Behavior Scales - II.
  • a) The VABS-II will be administered by the Principal Investigator or trained designee under the supervision of the Principal Investigator as part of the initial phone screening process.
  • Children with an ASD, particularly school-aged children and adolescents, may present with myriad prescribed psychotropic medications. Therefore, we will not exclude children on a variety of psychotropic medications; rather we will conduct a qualitative analysis to look at this issue.
  • No restrictions regarding race or gender will be applied to the autism or developmental disability sample. Every effort will be made not to over-represent any particular race and/or gender group.
  • Physically healthy prior to physical exam.
  • Previous exposure to visual systems. This will be assessed based on caregiver report during the phone screening using one question relating to the use of visual structure with the child.
  • History of:
  • +7 more criteria

You may not qualify if:

  • Participants with intelligence quotient standard scores \> 40.
  • Presence of the following genetic or progressive neurological disorders known to be causative of or potentially resulting in a phenotype similar to autism:
  • Fragile X,
  • Landau Kleffner, Rett Disorder,
  • Childhood Disintegrative Disorder, or
  • Tuberous Sclerosis, based on screening by clinical staff and subsequent review by medical staff as needed
  • Presence of vision or hearing loss or significant motor impairments.
  • Wards of the State.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Autism Spectrum Disorder

Condition Hierarchy (Ancestors)

Child Development Disorders, PervasiveNeurodevelopmental DisordersMental Disorders

Study Officials

  • Robin Gabriels, PsyD

    University of Colorado, Denver

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Masking Details
The medical examination teams (one chief medical resident and one nurse) will be blind to the study aim.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 13, 2017

First Posted

July 28, 2017

Study Start

September 1, 2007

Primary Completion

August 1, 2011

Study Completion

August 1, 2011

Last Updated

July 28, 2017

Record last verified: 2017-07

Data Sharing

IPD Sharing
Will not share